Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass

Clinical trial NCT02239146 · COMPLETED

Trial details

NCT number: NCT02239146
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Cardiac Surgery Requiring Cardiopulmonary Bypass

Start date: 2005-10-01
Primary completion: 2008-01-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.